Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty
Clinical trial NCT05283486 · COMPLETED
Trial details
- NCT number
- NCT05283486
- Sponsor
- TNF Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2023-06-07
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.